Journals / Annals of Medical Research / 2022 / Cilt: 29 - Sayı: 3

Evaluation of frailty in individuals aged 65 years and over, with and without diabetes: A cross-sectional study

Pages
267–271
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Further studies are needed to reveal the pathophysiology of frailty in diabetic elderly patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: This study aims to reveal the effect of frailty in patients aged 65 years and over with and without type 2 diabetes.
📊
Key Findings & Data:Materials and Methods: A total of 298 elderly individuals aged 65 and over, 149 type 2 diabetic individuals and 149 non-diabetic individuals as the control group, were included in the descriptive cross-sectional study.
💡
Conclusion & Impact:Further studies are needed to reveal the pathophysiology of frailty in diabetic elderly patients.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: This study aims to reveal the effect of frailty in patients aged 65 years and over with and without type 2 diabetes. Materials and Methods: A total of 298 elderly individuals aged 65 and over, 149 type 2 diabetic individuals and 149 non-diabetic individuals as the control group, were included in the descriptive cross-sectional study. Both groups were surveyed using Edmonton Frail Scale and socio-demographic data questionnaire. Results: The mean age of the participants was 70.68±5.45 years, and 63.4% (n=189) of participants were female. Of the diabetic patients, 61 (40.9%) patients were found to be frail, 41 (27.5%) to be prone to frailty, and 47 (31.5%) to be non-frail. In individuals without diabetes, 33 (22.1%) individuals were found to be frail, 22 (14.8%) to be prone to frailty, and 94 (63.1%) to be non-frail. When both groups were analyzed statistically in terms of frailty, it was observed that frailty increased significantly in diabetic patients (p < 0.05). Conclusion: This study has proved that frailty increases in type 2 diabetic patients compared to non-diabetic patients, the perception and assessment of aging may play a role under frailty, and quality of life is one of the factors that should be considered in the development of frailty. The high rates of falling and hospitalization in elderly diabetic patients necessitate taking necessary precautions. Further studies are needed to reveal the pathophysiology of frailty in diabetic elderly patients.

🔖

Cite This Article

KARSLI, Z., PAMUK, G., ÖNGEL, K. (2022). Evaluation of frailty in individuals aged 65 years and over, with and without diabetes: A cross-sectional study. Annals of Medical Research, Cilt: 29 - Sayı: 3, 267–271. https://ajindex.com/articles/445604

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Kılıç S, Simsek E, Nalbantgil S, Kırılganlık Sendromu ve Kardiyovasküler Sistem. MN Kardiyoloji 2016
  2. 23(4):200-206 2. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA
  3. Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001
  4. 56(3):M146-56. 3. Collard RM, Boter H, Schoevers RA, Oude Voshaar RC. Prevalence of frailty in community-dwelling older persons: a systematic review. J Am Geriatr Soc. 2012
  5. 60(8):1487-92. 4. Yanase T, Yanagita I, Muta K, Nawata H. Frailty in elderly diabetes patients. Endocr J. 2018
  6. 65(1):1-11. 5. Cruz-Jentoft AJ, Landi F, Schneider SM, et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing. 2014
  7. Horstman AM, Dillon EL, Urban RJ, Sheffield-Moore M. The role of androgens and estrogens on healthy aging and longevity. J Gerontol A Biol Sci Med Sci. 2012
  8. 52 7. Morley JE, Malmstrom TK, Rodriguez-Mañas L, Sinclair AJ. Frailty, sarcopenia and diabetes. J Am Med Dir Assoc. 2014
  9. Kalyani RR, Corriere M, Ferrucci L. Age-related and diseaserelated muscle loss: the effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol. 2014
  10. Regidor E, Franch J, Seguí M, Serrano R, Rodríguez-Artalejo F, Artola S. Traditional risk factors alone could not explain the excess mortality in patients with diabetes: a national cohort study of older Spanish adults. Diabetes Care. 2012
  11. Volpato S, Blaum C, Resnick H, Ferrucci L, Fried LP, Guralnik JM
  12. Women’s Health and Aging Study. Comorbidities and impairments explaining the association between diabetes and lower extremity disability: The Women’s Health and Aging Study. Diabetes Care. 2002
  13. Alemán-Mateo H, López Teros MT, Ramírez FA, Astiazarán- García H. Association between insulin resistance and low relative appendicular skeletal muscle mass: evidence from a cohort study in community-dwelling older men and women participants. J Gerontol A Biol Sci Med Sci. 2014
  14. Park SW, Goodpaster BH, Lee JS, et al. Health, Aging, and Body Composition Study. Excessive loss of skeletal muscle mass in older adults with type 2 diabetes. Diabetes Care. 2009
  15. 7 13. Yoon JW, Ha YC, Kim KM, et al. Hyperglycemia is associated with impaired muscle quality in ol